DAA Therapy in Pediatric Patients With Chronic Hepatitis C
Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The Mukh-Mantri Punjab Hepatitis C Relief Fund (MMPHCRF) is a public health initiative for
prevention and control of hepatitis C in the Punjab state, India. The efficacy of
decentralised public health services and safety of 12- or 24-weeks of sofosbuvir (SOF) +
ledipasvir (LDV) or SOF + daclatasvir (DCV) with or without ribavirin (RBV) in the treatment
of pediatric chronic hepatitis C will be assessed
Phase:
N/A
Details
Lead Sponsor:
Postgraduate Institute of Medical Education and Research